Inventor · disambiguated record
Robby Ruijtenbeek
Also filed as: RUIJTENBEEK ROBBY
8 granted patents·8 pending applications·10 citations·filing 2003–2018
76Inventor score
Top patents by PatentIndex Score
16 records- 0176US8962267B1Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapyDE WIJN RICHARD·Filed 2010·Granted Feb 24, 2015·8 cites·8 claims
- 0260US8962268B2Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC)DE WIJN RICHARD·Filed 2010·Granted Feb 24, 2015·1 cites·8 claims
- 0353US8617836B2Method for predicting the response of locally advanced rectal cancer to chemoradiotherapyBOENDER PIETER JACOB·Filed 2010·Granted Dec 31, 2013·1 cites·12 claims
- 0443US2011111980A1Method for profiling drug compoundsHOUTMAN RENE·Filed 2009·Application pending·0 cites
- 0541US2011257025A1Method for tumor classificationHOUTMAN RENE·Filed 2009·Application pending·0 cites
- 0640US2006234229A1Novel method for monitoring biomolecular interactionsVAN BEUNINGEN MARINUS G J·Filed 2003·Application pending·0 cites
- 0739US2006228813A1Method for immobilizing biomolecules on metal oxide substratesWU YING·Filed 2004·Application pending·0 cites
- 0837US9448237B2Modified tyrosine amino acids, peptides containing them, and their use for detecting hydrolase enzyme activityRUIJTENBEEK ROBBY·Filed 2012·Granted Sep 20, 2016·0 cites·5 claims
- 0937US9128087B2Nuclear receptor assayRUIJTENBEEK ROBBY·Filed 2007·Granted Sep 8, 2015·0 cites·12 claims
- 1037US2010203043A1Treatment and diagnosis of metastatic prostate cancer with inhibitors of epidermal growth factor receptor (egfr)REE ANNE H·Filed 2008·Application pending·0 cites
- 1134US2012021939A1Method for profiling drug compounds using protein kinase inhibitorsRUIJTENBEEK ROBBY·Filed 2010·Application pending·0 cites
- 1232US11802315B2Method for predicting the response of non-small-cell lung carcinoma patients to a medicamentPAMGENE BV·Filed 2018·Granted Oct 31, 2023·0 cites·8 claims
- 1332US10604786B2Method for predicting the response of melanoma patients to targeted pharmacotherapyPAMGENE BV·Filed 2016·Granted Mar 31, 2020·0 cites·11 claims
- 1432US2013217055A1Method for predicting tyrosine kinase inhibitor (tki) resistance in patients suffering from chronic myelogenous leukemia (cml)BOENDER PIETER JACOB·Filed 2011·Application pending·0 cites
- 1528US9075061B2Method for determining the estrogen receptor status of breast cancerRUIJTENBEEK ROBBY·Filed 2010·Granted Jul 7, 2015·0 cites·11 claims
- 1628US2012115754A1Method for diagnosing and/or typing renal cell carcinomaRUIJTENBEEK ROBBY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robby Ruijtenbeek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →